1.2M
Downloads
914
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Saturday Nov 23, 2024
Saturday Nov 23, 2024
A New ACR
Anti IL-17 on Entheseal Biopsy in PsA
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
Best Things I Saw Today in PsA
Cycling vs Switching after TNFi Failure in axSpA
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Sonelokimab in PsA: Phase 2 Data
Treating SpA
Saturday Nov 23, 2024
Saturday Nov 23, 2024
A New ACR
Best Things I Saw Today in PsA
Do TNFis and JAKis Prevent Cancer!?
Hold or continue JAKi and IL-17 when receiving COVID boosters?
JAK-pot! How fast do DMARDs work?
JAKi Studies at ACR
Poly-treatment of Polymyalgia Rheumatica?
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?
RA: One JAK to Rule Them All?
SELECT-GCA: Efficacy and Safety of Upadacitinib
"SELECT-GCA: Upadacitinib in Giant Cell Arteritis"
SELECTing the right patients: upadacitinib in GCA
So really, are JAKs Safe?
Summary of JAKi Studies
The Case for JAKi in PMR
The Real Value of JAKi is Beyond RA
When, What and How Long to Treat GCA & PMR
Worried about CV Risk and JAKi? What about the Steroids?
Friday Nov 22, 2024
Friday Nov 22, 2024
A Fibroblast Renaissance
A New ACR
A useful urinary biomarker for lupus nephritis
ANA+ and no Autoimmune Disease? Check the liver
CAR-T Therapy and Lupus
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis
Evaluating ANA Patterns and Titers with AI
Neuropsychiatric Lupus: The Forgotten Symptoms
The 2024 ACR Guidelines for Lupus Nephritis
Vaccine Responses:The DMARD Counts
What is MCTD? The Great Debate
Friday Nov 22, 2024
Friday Nov 22, 2024
A New ACR
Assessing ASAS Criteria: CLASSIC Study Results
Assessment and management of axSpA
Assessment of axSpA
Carotid Doppler Ultrasound Screening in Axial SpA
Cycling vs Switching after TNFi Failure in axSpA
Defining Difficult to Manage axSpA
Difficult to manage AxSpA
DISH in SpA
Gender Differences in AxSpA
Highlights in axSpA
Hot Topics in axSpA
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Machine Learning for Predicting Flares in axSpA
Precision Immunotherapy in Axial SpA
PREDICT-SpA: Evaluating the influence of gender on disease assessment tools
Treating SpA
What is a Positive MRI in Spondyloarthritis?
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
Friday Nov 22, 2024
Friday Nov 22, 2024
A New ACR
Apremilast Benefits and Risks in PsA
Best Things I Saw Today in PsA
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact
Biologic Monotherapy vs Combination with cDMARDs in PsA
Do TNFis and JAKis Prevent Cancer!?
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Potential Impact of Weight Loss Drugs in Rheumatic Diseases
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis
PsA Potpourri
PsA Ultrasound Updates
PsA: Impact of Sex
Sex Differences in Psoriatic Arthritis
The Psoriatic March: PsA before PsO
Apremilast in PsA: Results from Mosaic Trial
Anti IL-17 on Entheseal Biopsy in PsA
Friday Nov 22, 2024
Friday Nov 22, 2024
Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta
The Case for JAKi in PMR:Dr. David Liew
Treatment Strategies in RA:Dr. Victoria Konzett
What's New in Relapsing Polychondritis?:Dr. Bella Mehta
Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew
Wednesday Nov 20, 2024
Wednesday Nov 20, 2024
ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope
Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela
Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela
Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway
Wednesday Nov 20, 2024
Wednesday Nov 20, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
Tuesday Nov 19, 2024
Tuesday Nov 19, 2024
ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope
Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros
Can We Make Clinical Trials Better?:Dr. Janet Pope
Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey
IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian Sattui
IVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed
Machine Learning for Predicting Flares in axSpA:Dr. Sheila Reyes
So really, are JAKs Safe?:Dr. Janet Pope
Tackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey, Louise Pollard and Bharat Kumar
The 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes
The Real Value of JAKi is Beyond RA:Dr. David Liew
Vaccine Responses:The DMARD Counts:Dr. David Liew
Tuesday Nov 19, 2024
Tuesday Nov 19, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!